Ryuichi Ueoka Selected Research

Polyethylene Glycols (Polyethylene Glycol)

1/2014	Therapeutic effects of cationic hybrid liposomes on the hepatic metastasis of colon carcinoma along with apoptosis in vivo.
6/2013	Hybrid liposomes inhibit tumor growth and lung metastasis of murine osteosarcoma cells.
2/2012	Hybrid liposomes inhibit growth and invasion of human osteosarcoma cells leading to apoptosis.
2/2012	Selective accumulation and growth inhibition of hybrid liposomes to human hepatocellular carcinoma cells in relation to fluidity of plasma membranes.
7/2011	Selective accumulation of hybrid liposomes into adult T-cell leukemia cells along with induction of apoptosis.
1/2011	Remarkable inhibitory effects of hybrid liposomes on growth of human colon cancer cells through induction of cell cycle arrest along with apoptosis.
1/2011	[Experimental therapeutic effects of hybrid liposomes on the Alzheimer's disease in vitro].
6/2010	Hybrid liposomes inhibit the growth of cholangiocarcinoma by induction of cell cycle arrest in G1 phase.
4/2009	[Marked therapeutic effects of hybrid liposomes on the hepatic metastasis of colon carcinoma].
7/2008	Remarkably high inhibitory effects of docosahexaenoic acid incorporated into hybrid liposomes on the growth of tumor cells along with apoptosis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ryuichi Ueoka Research Topics

Disease

29	Neoplasms (Cancer) 01/2016 - 04/2002
15	Carcinoma (Carcinomatosis) 01/2014 - 04/2002
11	Neoplasm Metastasis (Metastasis) 11/2019 - 04/2009
6	Hepatocellular Carcinoma (Hepatoma) 07/2012 - 11/2002
4	Breast Neoplasms (Breast Cancer) 01/2013 - 02/2006
3	Lung Neoplasms (Lung Cancer) 11/2019 - 01/2016
3	Rheumatoid Arthritis 07/2015 - 01/2011
3	Infections 02/2015 - 03/2010
3	Lymphoma (Lymphomas) 04/2009 - 06/2006
2	Arthritis (Polyarthritis) 07/2015 - 01/2011
2	Colorectal Neoplasms (Colorectal Cancer) 09/2014 - 11/2012
2	Osteosarcoma (Osteogenic Sarcoma) 06/2013 - 02/2012
2	Carcinogenesis 01/2012 - 01/2011
2	Neuroblastoma 04/2011 - 01/2011
2	Leukemia 03/2011 - 06/2005
2	Primary Effusion Lymphoma 07/2010 - 03/2010
2	Melanoma (Melanoma, Malignant) 09/2004 - 01/2003
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2016
1	Experimental Arthritis 07/2015
1	Wounds and Injuries (Trauma) 02/2012
1	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 07/2011
1	Liver Neoplasms (Liver Cancer) 05/2011
1	Ototoxicity 01/2011
1	Alzheimer Disease (Alzheimer's Disease) 01/2011
1	Neoplastic Cell Transformation 01/2011
1	Colonic Neoplasms (Colon Cancer) 01/2011
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2011
1	Cholangiocarcinoma 06/2010
1	Renal Cell Carcinoma (Grawitz Tumor) 02/2010
1	Necrosis 02/2006

Drug/Important Bio-Agent (IBA)

45	Liposomes (Liposome)IBA 01/2016 - 04/2002
27	Dimyristoylphosphatidylcholine (DMPC)IBA 01/2016 - 04/2002
15	Therapeutic UsesIBA 07/2015 - 04/2009
15	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2014 - 11/2002
10	Ether (Diethyl Ether)IBA 01/2014 - 11/2002
7	Pharmaceutical PreparationsIBA 01/2013 - 04/2002
4	polyoxyethylene (23) dodecyletherIBA 07/2015 - 03/2005
4	LipidsIBA 02/2012 - 09/2008
3	dihydroceramide desaturaseIBA 11/2019 - 01/2016
3	Surface-Active Agents (Surfactants)IBA 01/2013 - 04/2002
3	EthersIBA 02/2012 - 01/2011
3	Caspase 3 (Caspase-3)IBA 02/2012 - 06/2005
3	Docosahexaenoic AcidsIBA 01/2011 - 03/2008
3	Polysorbates (PSML)FDA Link 07/2008 - 04/2002
2	polyoxyethylene(25)dodecyl etherIBA 09/2014 - 11/2012
2	Phosphatidylcholines (Phosphatidylcholine)IBA 01/2014 - 01/2011
2	human ERBB2 proteinIBA 01/2013 - 01/2012
2	Trastuzumab (Herceptin)FDA Link 01/2013 - 01/2012
2	CaspasesIBA 07/2012 - 02/2006
2	Antineoplastic Agents (Antineoplastics)IBA 05/2011 - 09/2008
2	Prothrombin (Factor II)IBA 01/2011 - 12/2007
2	Phospholipids (Phosphatides)FDA LinkGeneric 01/2011 - 02/2006
2	acarboxyprothrombin (PIVKA)IBA 01/2011 - 12/2007
2	Biomarkers (Surrogate Marker)IBA 01/2011 - 12/2007
2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 07/2008 - 03/2008
2	sorbitan monooleate (Span 80)IBA 07/2008 - 03/2008
2	Polidocanol (Laureth)FDA Link 03/2005 - 01/2003
1	RV 538 (PDMP)IBA 01/2016
1	SphingolipidsIBA 01/2016
1	ceramide glucosyltransferaseIBA 01/2016
1	CeramidesIBA 01/2016
1	CytokinesIBA 07/2015
1	GUT-70IBA 02/2015
1	cepharanthineIBA 05/2014
1	diethanolamineIBA 01/2014
1	ChloridesIBA 01/2014
1	TrehaloseIBA 01/2013
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 01/2013
1	deoxyuridine triphosphateIBA 01/2013
1	matrigelIBA 02/2012
1	PowdersIBA 01/2012
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 05/2011
1	Glutamic Acid (Glutamate)FDA Link 05/2011
1	Ammonium CompoundsIBA 01/2011
1	dimyristoylphosphatidylserineIBA 01/2011
1	AgarIBA 01/2011
1	Amyloid (Amyloid Fibrils)IBA 01/2011
1	Gentamicins (Gentamicin)FDA LinkGeneric 01/2011
1	Peptides (Polypeptides)IBA 01/2011
1	PropaneIBA 01/2011
1	Unithiol (DMPS)IBA 01/2011
1	DystrophinIBA 01/2011
1	Hematoxylin (Haematoxylon)IBA 07/2010
1	Eosine Yellowish-(YS) (Eosin)IBA 07/2010
1	alpha-Tocopherol FDA Link 07/2008
1	Vitamin E FDA LinkGeneric 07/2008
1	alpha-Linolenic Acid (Linolenic Acid)IBA 07/2008
1	EstersIBA 07/2008
1	Caspase 8 (Caspase-8)IBA 06/2005
1	Caspase 9IBA 06/2005
1	SolventsIBA 09/2004
1	sorbitan monolaurateIBA 09/2004
1	naphthaIBA 09/2004

Therapy/Procedure

11	Drug Therapy (Chemotherapy) 06/2013 - 06/2006
4	Intravenous Injections 01/2014 - 07/2010
3	Aftercare (After-Treatment) 09/2014 - 03/2008
1	Oral Administration 01/2012
1	Immunotherapy 01/2012
1	Intraperitoneal Injections 04/2011
1	Cell Transplantation 01/2011